Continuous Tableting Lines

At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.

Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:

 

  • by collecting more information during R&D phase, in a short time with less product
  • by excluding risky, time- and product consuming scale-up exercises
  • by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
  • by incorporating flexible batch size (JIT production), reducing inventory
  • by reducing the energy cost per tablet, reducing environmental impact. 

GEA Insights

GEA helps dairy cows avoid lameness with AI solution

GEA minimizes dairy cow lameness with AI solution

GEA CattleEye alerts dairy farmers when cows are lame, enabling them to address health issues quickly to ensures optimal cow health and milk yield.

Clothes recycled by GEA

GEA solutions enable fiber-to-fiber recycling of textiles

Chemical recycling solutions from GEA allow mixed fiber textiles with PET to be recycled and made into new sustainable clothing.

Workers working at Hovione

Advancing continuous pharmaceutical manufacturing

GEA and partners innovate flexible continuous processing technologies, transforming pharmaceutical development and manufacturing for a modernized future.

Receive news from GEA

Stay in touch with GEA innovations and stories by signing up for news from GEA.

Contact us

We are here to help! With just a few details we will be able to respond to your inquiry.